Zhengdong Cai
Jiangsu University(CN)Shanghai Jiao Tong University(CN)Shanghai Chest Hospital(CN)Shanghai Cancer Institute(CN)Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital(CN)Jintan People's Hospital(CN)Shanghai First People's Hospital(CN)First Hospital of China Medical University(CN)University of Hong Kong - Shenzhen Hospital(CN)University of Hong Kong(HK)China Medical University(CN)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, Bone Tumor Diagnosis and Treatments, Cancer-related molecular mechanisms research, Cytokine Signaling Pathways and Interactions, RNA modifications and cancer
Most-Cited Works
- → Immunogenic cell death in cancer therapy: Present and emerging inducers(2019)706 cited
- → Erianin induces G2/M-phase arrest, apoptosis, and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells in vitro and in vivo(2016)226 cited
- → Arsenic sulfide induces apoptosis and autophagy through the activation of ROS/JNK and suppression of Akt/mTOR signaling pathways in osteosarcoma(2017)152 cited
- → Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis(2018)149 cited
- → Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma(2019)144 cited
- → Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3(2017)